Please Wait.....
Report
US Alzheimer's Disease Diagnostic Market Research Report Forecast to 2040
Market Report I 2024-02-10 I 98 Pages I Market Research Future
US Alzheimer's Disease Diagnostic Market Research Report Forecast to 2040
Market Overview
US Alzheimer's Disease Diagnostic market is anticipated to register a notable CAGR of 7.92% during the review period. Alzheimer's disease, often referred to simply as Alzheimer's, is a progressive and degenerative brain disorder that primarily affects cognitive functions, especially memory, thinking, and behavior. It is the most common cause of dementia in older adults. The disease is characterized by the accumulation of abnormal protein deposits, including beta-amyloid plaques and tau tangles, in the brain, which lead to the death of brain cells and the disruption of neural pathways.
The US Alzheimer's disease diagnostic market is emerging due to Increasing prevalence of Alzheimer's disease, growing aging population and raising awareness about Alzheimer's disease. Additionally, growth of telemedicine and remote monitoring technologies presents opportunities for Alzheimer's disease diagnostics market in the future. However, the high cost of diagnosis might hamper the market's growth in the forecast period.
Market Segmentation
Based on product, the market has been segmented into reagents & kits and equipment & accessories.
Based on the type, the market has been segmented into early onset Alzheimer disease and late onset Alzheimer disease.
Based on test type, the US Alzheimer's disease diagnostic market has been segmented into genetic testing, brain imaging, neurological exams, mini mental state exam (MMSE), and others.
Based on end user, the US Alzheimer's disease diagnostic market has been segmented into hospitals, and diagnostic laboratories, and others.
Major Players
The Key market players in the US Alzheimer's Disease Diagnostic market are Siemens, F. Hoffmann-La Roche Ltd, GE Healthcare, Fujirebio, QYNAPSE, and Koninklijke Philips N.V.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 14
2 MARKET INTRODUCTION 16
2.1 DEFINITION 16
2.2 SCOPE OF THE STUDY 16
2.3 RESEARCH OBJECTIVE 16
2.4 MARKET STRUCTURE 17
3 RESEARCH METHODOLOGY 18
3.1 OVERVIEW 18
3.2 DATA FLOW 19
3.2.1 DATA MINING PROCESS 20
3.3 PURCHASED DATABASE: 21
3.4 SECONDARY SOURCES: 22
3.4.1 SECONDARY RESEARCH DATA FLOW: 23
3.5 PRIMARY RESEARCH: 24
3.5.1 PRIMARY RESEARCH DATA FLOW: 25
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 26
3.6.1 REVENUE ANALYSIS APPROACH 26
3.7 DATA FORECASTING 27
3.7.1 DATA FORECASTING TECHNIQUE 27
3.8 DATA MODELING 28
3.8.1 MICROECONOMIC FACTOR ANALYSIS: 28
3.8.2 DATA MODELING: 29
3.9 TEAMS AND ANALYST CONTRIBUTION 31
4 MARKET DYNAMICS 33
4.1 INTRODUCTION 33
4.2 DRIVERS 34
4.2.1 INCREASING PREVALENCE OF ALZHEIMER'S DISEASE 34
4.2.2 GROWING AGING POPULATION 34
4.2.3 RAISING AWARENESS ABOUT ALZHEIMER'S DISEASE 35
4.3 RESTRAINTS 36
4.3.1 HIGH COST OF DIAGNOSIS 36
4.4 OPPORTUNITY 37
4.4.1 GROWTH OF TELEMEDICINE AND REMOTE MONITORING TECHNOLOGIES PRESENTS OPPORTUNITIES FOR ALZHEIMER'S DISEASE DIAGNOSTICS MARKET 37
5 MARKET FACTOR ANALYSIS 38
5.1 VALUE CHAIN ANALYSIS 38
5.1.1 R&D AND DESIGNING 39
5.1.2 MANUFACTURING 39
5.1.3 DISTRIBUTION, MARKETING, AND SALES 39
5.1.4 POST-SALES MONITORING 39
5.2 PORTER'S FIVE FORCES MODEL 40
5.2.1 BARGAINING POWER OF SUPPLIERS 40
5.2.2 BARGAINING POWER OF BUYERS 41
5.2.3 THREAT OF NEW ENTRANTS 41
5.2.4 THREAT OF SUBSTITUTES 41
5.2.5 INTENSITY OF RIVALRY 41
5.3 IMPACT ANALYSIS OF COVID-19 ON ALZHEIMER'S DISEASE DIAGNOSTIC MARKET 41
5.3.1 OVERVIEW 41
5.4 MARKET KEY TRENDS FOR ALZHEIMER'S DISEASE DIAGNOSTIC MARKET 42
5.5 ANALYSIS OF INTELLECTUAL PROPERTY (IP) & STARTUPS 42
5.5.1 INTELLECTUAL PROPERTY (IP) 42
5.5.2 STARTUPS 43
5.6 CHANGES IN HEALTHCARE POLICIES 43
5.7 CLINICAL DIAGNOSIS OF ALZHEIMER'S DISEASE 44
5.8 PROVIDER AND PAYER COVERAGE POLICIES FOR ALZHEIMER'S DISEASE DIAGNOSTICS 45
5.9 ALZHEIMER'S DISEASE PRE-DIAGNOSIS AND DIAGNOSIS IN THE US 45
5.10 ALZHEIMER'S DISEASE TREATMENT/ DISEASE MANAGEMENT AND MONITORING 46
6 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, BY PRODUCT 48
6.1 OVERVIEW 48
7 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, BY TYPE 51
7.1 OVERVIEW 51
8 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, BY TEST TYPE 54
8.1 OVERVIEW 54
9 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, BY END USER 58
9.1 OVERVIEW 58
10 COMPETITIVE LANDSCAPE 62
10.1 INTRODUCTION 62
10.2 MARKET SHARE ANALYSIS, 2022 63
10.3 COMPETITOR DASHBOARD 64
10.4 PUBLIC PLAYERS STOCK SUMMARY 65
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 65
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 66
10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL 66
10.6.1 PARTNERSHIP 66
11 COMPANY PROFILES 67
11.1 SIEMENS 67
11.1.1 COMPANY OVERVIEW 67
11.1.2 FINANCIAL OVERVIEW 68
11.1.3 PRODUCTS OFFERED 69
11.1.4 KEY DEVELOPMENTS 70
11.1.5 SWOT ANALYSIS 70
11.1.6 KEY STRATEGIES 71
11.2 F. HOFFMANN-LA ROCHE LTD 72
11.2.1 COMPANY OVERVIEW 72
11.2.2 FINANCIAL OVERVIEW 73
11.2.3 PRODUCTS OFFERED 73
11.2.4 KEY DEVELOPMENTS 74
11.2.5 SWOT ANALYSIS 74
11.2.6 KEY STRATEGIES 75
11.3 GE HEALTHCARE 76
11.3.1 COMPANY OVERVIEW 76
11.3.2 FINANCIAL OVERVIEW 77
11.3.3 PRODUCTS OFFERED 77
11.3.4 KEY DEVELOPMENTS 78
11.3.5 SWOT ANALYSIS 78
11.3.6 KEY STRATEGIES 79
11.4 KONINKLIJKE PHILIPS N.V. 80
11.4.1 COMPANY OVERVIEW 80
11.4.2 FINANCIAL OVERVIEW 81
11.4.3 PRODUCTS OFFERED 81
11.4.4 KEY DEVELOPMENTS 82
11.4.5 SWOT ANALYSIS 83
11.4.6 KEY STRATEGIES 83
11.5 BMG LABTECH 84
11.5.1 COMPANY OVERVIEW 84
11.5.2 FINANCIAL OVERVIEW 84
11.5.3 PRODUCTS OFFERED 84
11.5.4 KEY DEVELOPMENTS 84
11.5.5 KEY STRATEGIES 85
11.6 BIOASSAY SYSTEMS 86
11.6.1 COMPANY OVERVIEW 86
11.6.2 FINANCIAL OVERVIEW 86
11.6.3 PRODUCTS OFFERED 86
11.6.4 KEY DEVELOPMENTS 87
11.6.5 SWOT ANALYSIS 87
11.6.6 KEY STRATEGIES 87
11.7 SCIENCELL RESEARCH LABORATORIES, INC 88
11.7.1 COMPANY OVERVIEW 88
11.7.2 FINANCIAL OVERVIEW 88
11.7.3 PRODUCTS OFFERED 88
11.7.4 KEY DEVELOPMENTS 88
11.7.5 KEY STRATEGIES 89
11.8 FUJIREBIO 90
11.8.1 COMPANY OVERVIEW 90
11.8.2 FINANCIAL OVERVIEW 90
11.8.3 PRODUCTS OFFERED 90
11.8.4 KEY DEVELOPMENTS 91
11.8.5 KEY STRATEGIES 91
11.9 QUANTERIX 92
11.9.1 COMPANY OVERVIEW 92
11.9.2 FINANCIAL OVERVIEW 92
11.9.3 PRODUCTS OFFERED 92
11.9.4 KEY DEVELOPMENTS 93
11.9.5 KEY STRATEGIES 93
11.10 QYNAPSE 94
11.10.1 COMPANY OVERVIEW 94
11.10.2 FINANCIAL OVERVIEW 94
11.10.3 PRODUCTS OFFERED 94
11.10.4 KEY DEVELOPMENTS 95
11.10.5 KEY STRATEGIES 95
12 DATA CITATIONS 96
?
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 29
TABLE 2 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, BY PRODUCT, 2019-2040 (USD MILLION) 49
TABLE 3 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, BY TYPE, 2019-2040 (USD MILLION) 52
TABLE 4 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, BY TEST TYPE, 2019-2040 (USD MILLION) 56
TABLE 5 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, FOR BRAIN IMAGING, BY TYPE, 2019-2040 (USD MILLION) 56
TABLE 6 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, BY END USER, 2019-2040 (USD MILLION) 59
TABLE 7 PUBLIC PLAYERS STOCK SUMMARY 65
TABLE 8 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 65
TABLE 9 PRODUCT LAUNCH/PRODUCT APPROVAL 66
TABLE 10 PARTNERSHIP 66
TABLE 11 SIEMENS: PRODUCTS OFFERED 69
TABLE 12 SIEMENS: KEY DEVELOPMENTS 70
TABLE 13 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 73
TABLE 14 F. HOFFMANN-LA ROCHE LTD: KEY DEVELOPMENTS 74
TABLE 15 GE HEALTHCARE: PRODCUTS OFFERED 77
TABLE 16 KONINKLIJKE PHILIPS N.V.: PRODCUTS OFFERED 81
TABLE 17 KONINKLIJKE PHILIPS N.V.: KEY DEVELOPMENTS 82
TABLE 18 BMG LABTECH: PRODCUTS OFFERED 84
TABLE 19 BIOASSAY SYSTEMS: PRODUCTS OFFERED 86
TABLE 20 SCIENCELL RESEARCH LABORATORIES, INC: PRODUCTS OFFERED 88
TABLE 21 FUJIREBIO: PRODCUTS OFFERED 90
TABLE 22 FUJIREBIO: KEY DEVELOPMENTS 91
TABLE 23 QUANTERIX: PRODCUTS OFFERED 92
TABLE 24 QYNAPSE: PRODCUTS OFFERED 94
TABLE 25 QYNAPSE: KEY DEVELOPMENTS 95
?
LIST OF FIGURES
FIGURE 1 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET: STRUCTURE 17
FIGURE 2 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032) 33
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2040) 35
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 36
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET 40
FIGURE 6 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, PRODUCT SEGMENT ATTRACTIVENESS, 2022 & 2040 (USD MILLION) 48
FIGURE 7 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, BY PRODUCT, 2022 & 2040 (USD MILLION) 49
FIGURE 8 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET SHARE (%), BY PRODUCT, 2022 50
FIGURE 9 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, TYPE SEGMENT ATTRACTIVENESS, 2022 & 2040 (USD MILLION) 51
FIGURE 10 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, BY TYPE, 2022 & 2040 (USD MILLION) 52
FIGURE 11 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET SHARE (%), BY TYPE, 2022 53
FIGURE 12 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, TEST TYPE, SEGMENT ATTRACTIVENESS, 2022 & 2040 (USD MILLION) 55
FIGURE 13 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, BY TEST TYPE, 2022 & 2040 (USD MILLION) 55
FIGURE 14 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET SHARE (%), BY TEST TYPE, 2022 57
FIGURE 15 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, END USER SEGMENT ATTRACTIVENESS, 2022 & 2040 (USD MILLION) 58
FIGURE 16 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET, BY END USER, 2022 & 2040 (USD MILLION) 59
FIGURE 17 US ALZHEIMER'S DISEASE DIAGNOSTIC MARKET SHARE (%), BY END USER, 2022 60
FIGURE 18 US ALZHEIMER'S DISEASE DIAGNOSTICS MARKET PLAYERS: COMPETITIVE ANALSIS, 2022 63
FIGURE 19 COMPETITOR DASHBOARD: US ALZHEIMER'S DISEASE DIAGNOSTICS MARKET 64
FIGURE 20 SIEMENS: FINANCIAL OVERVIEW SNAPSHOT 68
FIGURE 21 SIEMENS: SWOT ANALYSIS 70
FIGURE 22 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 73
FIGURE 23 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 74
FIGURE 24 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT 77
FIGURE 25 GE HEALTHCARE: SWOT ANALYSIS 78
FIGURE 26 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT 81
FIGURE 27 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS 83
FIGURE 28 BIOASSAY SYSTEMS: SWOT ANALYSIS 87
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security